Table of Content - Coronavirus Treatment Drugs Market

The coronavirus treatment drugs comprises therapeutics which are used for treatment of the novel coronavirus. There are various drug classes such as corticosteroids, anti-viral, monoclonal antibodies, Kinase inhibitors which can be used for treatment of the coronavirus. The coronavirus is generally treated depending on severity of symptoms such as severe, moderate and mild. The common symptoms of coronavirus are cold, fever, breathlessness, headache, and stomach pain.

Market Dynamics

Key players are focusing on obtaining product approvals in order to strengthen their position in the global coronavirus treatment drugs market. For instance, in June 2020, Glenmark Pharmaceuticals Limited, a pharmaceutical company in India, launched the first orally administered tablet, Fabiflu, for the treatment of patients suffering from mild and moderate symptoms of COVID-19. Fabiflu is available as a 200 mg tablet, has been priced at US$ 1 per tablet. A strip of 34 tablets will cost US$ 47.55 to the patients in India.

Furthermore, key companies are focusing on inorganic strategies such agreements in order to strengthen their position in the global coronavirus treatments drugs market. For instance, in September 2020, Dr Reddy's Laboratories, an Indian pharmaceutical company, announced the launch of Remdesivir under the brand name, Redyx, for the Indian market. The launch of Redyx for treatment for COVID-19 is because of licensing agreement of Dr Reddy Laboratories with Gilead Sciences Inc. which grants Dr Reddy's Laboratories the right to register, manufacture and sell Remdesivir, as a potential treatment for COVID-19 in 127 countries including India.

Key features of the study

This report studies the current scenario as well as the future potential of the global coronavirus treatment drugs market. The market for coronavirus treatment drugs is segmented on the basis of drug class, route of administration, distribution channel, and region.
This report provides in-depth analysis of the global coronavirus treatment drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
It profiles leading players in the global coronavirus treatment drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global coronavirus treatment drugs market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global coronavirus treatment drugs market.

Market Segmentation

By Drug Class (Revenue, USD Bn, 2021-2033)
- Corticosteroids
- Anti-viral drugs
- Monoclonal Antibodies
- Kinase Inhibitors
- Others
By Route of Administration (Revenue, USD Bn, 2021-2033)
- Oral
- Intravenous
By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region (Revenue, USD Bn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Serum Institute of India
- Pfizer Inc.
- AstraZeneca plc.
- Bharat Biotech International Limited
- Cadila Healthcare Limited
- Johnson & Johnson
- Moderna
- GlaxoSmithKline plc.
- CanSino Biologics
- Sinovac Biotech
- Novavax, Inc.
- Glenmark Pharmaceuticals Limited
- Merck & Co., Inc.
- Reddy's Laboratories

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Coronavirus Treatment Drugs Market, By Drug Class
  - Global Coronavirus Treatment Drugs Market, By Route of Administration
  - Global Coronavirus Treatment Drugs Market, By Distribution Channel
  - Global Coronavirus Treatment Drugs Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
Global Coronavirus Treatment Drugs Market, By Drug Class, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Corticosteroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anti-viral drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Monoclonal Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Kinase Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Global Coronavirus Treatment Drugs Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Intravenous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Global Coronavirus Treatment Drugs Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Global Coronavirus Treatment Drugs Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026 & 2033, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Serum Institute of India
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AstraZeneca plc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bharat Biotech International Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cadila Healthcare Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Moderna
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- CanSino Biologics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sinovac Biotech
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novavax, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Glenmark Pharmaceuticals Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Dr. Reddy's Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE